August 13, 2020
Vineti Inc. named to the 2020 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups
Vineti Inc. named to the 2020 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups
Vineti Inc. recognized for achievements in advancing Industrialize Personalized and High-Value Therapeutics
NEW YORK, August 13, 2020 — CB Insights today named Vineti Inc. to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world.
The 2020 Digital Health 150 cohort highlights startups that are reimagining the lines of the traditional healthcare experience across 12 categories, from Virtual Care Delivery and Clinical Trials, to Drug Discovery and Specialty Care. Countries represented this year include Canada, China, Israel, France, the United Kingdom, and the United States, among others.
“This year’s Digital Health 150 is our most global ever, covering the best private healthcare companies from 17 countries. Beyond geographic diversity, these companies are innovating across the entire healthcare value chain, spanning technologies that benefit pharma & biotech companies, to payers, hospitals, insurers, and more,” said CB Insights CEO Anand Sanwal. “Last year’s Digital Health 150 winners saw numerous exits and went on to raise nearly $5 billion in investor financing after being recognized. We look forward to seeing the success of this year’s class of the best in digital health.”
“We’re thrilled to be nominated to the 2020 Digital Health 150 alongside so many other truly innovative companies,” said Vineti CEO and Co-founder Amy DuRoss. “Vineti is focused on industrializing advanced therapies so that all patients in need can benefit. We’re very honored that CB Insights chose to recognize this important work.”
Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum.
The Vineti team is united in its passion and commitment to opening up access to advanced therapies through a digital platform that provides the essential infrastructure for a personalized medicine ecosystem. With the number of new personalized therapies in development continuing to grow, Vineti is paving the way for efficiency, access, and global reach. As a leader in personalized therapy digital technology, Vineti is working to create a world where individualized therapies can reach all who need them.
Quick facts on the 2020 Digital Health 150:
- The 2020 Digital Health 150 startups have raised over $20B in funding across 600+ deals from 900+ unique investors.
- The list includes 12 unicorns (companies that have reached a valuation of $1B+) focused on a diverse range of digital health solutions, including telehealth, insurance, and robotic surgical systems.
- Many have formed partnerships with key industry players like the American Heart Association, Cigna, and Mount Sinai Health System.
The Digital Health 150 Companies:
About CB Insights
At CB Insights, we believe the most complex strategic business questions are best answered with facts. We are a machine intelligence company that synthesizes, analyzes and visualizes millions of documents to give our clients fast, fact-based insights. Serving the majority of the Fortune 100, we give companies the power to make better decisions, take control of their own future, and capitalize on change.
Contact:
Keith Swiader, Manager – PR & Communications
keith.swiader@cbinsights.com
917-214-1028
About Vineti Inc.
Vineti is the first commercial, configurable cloud-based platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE and the Mayo Clinic to solve the key challenges that patients, medical providers, biopharmaceutical companies and regulators face in the delivery and commercialization of individualized therapies. Now a fully independent company, Vineti offers a digital platform of record to integrate logistics, manufacturing and clinical data for personalized therapies. The Vineti platform supports the full continuum of patient-specific therapies, including cancer vaccines and autologous and allogeneic therapies. The company is expanding rapidly, and Vineti’s Personalized Therapy Management (PTM) platform was in use in hundreds of leading medical centers worldwide in 2019, on behalf of multiple biopharmaceutical partners. In 2019, the World Economic Forum selected Vineti as a Global Technology Pioneer.
https://vineti.com/
Contact:
Stacy Henry
press@vineti.com